Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Familial amyloidotic polyneuropathy (FAP) type I, the most common dominantly inherited form of amyloidosis, is caused by a Val-to-Met point mutation at position 30 (Val(30)-->Met) in the protein transthyretin. 10973857

2000

dbSNP: rs3743930
rs3743930
0.040 GeneticVariation BEFREE We compared the frequencies of seven MEFV mutations (M694V, M680I, V726A, M694I, K695R, R761H, E148Q) and the clinical findings in 20 Turkish FMF patients who had not developed amyloidosis by the age of 40 years in the absence of colchicine therapy, with those in 27 Turkish amyloidosis patients. 11029479

2000

dbSNP: rs61752717
rs61752717
0.100 GeneticVariation BEFREE Initial studies have suggested that the presence of the Met694Val mutation carry a significant risk for the development of amyloidosis. 11139244

2001

dbSNP: rs767006697
rs767006697
0.010 GeneticVariation BEFREE Is the Ala138Gly alteration of MEFV gene important for amyloidosis? 11139244

2001

dbSNP: rs61752717
rs61752717
0.100 GeneticVariation BEFREE The genotype-phenotype analysis showed a significant association (P < 0.001) between amyloidosis and the presence of mutations at codon 694 in exon 10 (both M694V and M694I). 11175300

2001

dbSNP: rs28940578
rs28940578
0.020 GeneticVariation BEFREE The genotype-phenotype analysis showed a significant association (P < 0.001) between amyloidosis and the presence of mutations at codon 694 in exon 10 (both M694V and M694I). 11175300

2001

dbSNP: rs1440063914
rs1440063914
0.010 GeneticVariation BEFREE The genotype-phenotype analysis showed a significant association (P < 0.001) between amyloidosis and the presence of mutations at codon 694 in exon 10 (both M694V and M694I). 11175300

2001

dbSNP: rs121918088
rs121918088
TTR
0.010 GeneticVariation BEFREE This is the second report of transthyretin (TTR) amyloidosis in a patient who had ATTR Tyr114His diagnosed by mass spectrometry and gene analysis. 11409031

2001

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE Because leptomeningeal amyloidosis occurs in FAP ATTR Val30 Met as the progression of the disease, this information suggests that in addition to peripheral neuropathy, disorders of the central nervous system (CNS) should be given an attention in patients who underwent sequential liver transplantation using an explanted FAP ATTR Val30 Met patient's liver. 11477356

2001

dbSNP: rs28933979
rs28933979
TTR
0.100 GeneticVariation BEFREE In addition to the findings characteristic of homozygosity for ATTR Val30Met such as vitreous amyloidosis and relatively less autonomic involvements, this case had the unique findings of motor-dominant sensorimotor polyneuropathy and unusual sural nerve biopsy specimen results. 11709003

2001

dbSNP: rs76992529
rs76992529
TTR
0.100 GeneticVariation BEFREE The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. 11752443

2001

dbSNP: rs759304648
rs759304648
GSN
0.030 GeneticVariation BEFREE Hereditary gelsolin amyloidosis (AGel amyloidosis) is a systemic disorder reported worldwide in kindreds with a G654A or G654T gelsolin gene mutation. 12071640

2002

dbSNP: rs920832709
rs920832709
GSN
0.030 GeneticVariation BEFREE Hereditary gelsolin amyloidosis (AGel amyloidosis) is a systemic disorder reported worldwide in kindreds with a G654A or G654T gelsolin gene mutation. 12071640

2002

dbSNP: rs76992529
rs76992529
TTR
0.100 GeneticVariation BEFREE A high prevalence of some mutations like Val122Ile which is identified in 3% of African Americans indicates the necessity of thorough investigation of patients suspected of having, or to be at risk of developing, TTR amyloidosis. 12553428

2002

dbSNP: rs61752717
rs61752717
0.100 GeneticVariation BEFREE Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation. 12563686

2003

dbSNP: rs104894664
rs104894664
TTR
0.030 GeneticVariation BEFREE Herein we demonstrate that small-molecule tetramer stabilizers represent an attractive therapeutic strategy to inhibit A25T misfolding and CNS amyloidosis. 12649341

2003

dbSNP: rs121918100
rs121918100
TTR
0.020 GeneticVariation BEFREE Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. 12771253

2003

dbSNP: rs121918098
rs121918098
TTR
0.030 GeneticVariation BEFREE Selected small molecule tetramer stabilizers can transform D18G from a monomeric aggregation-prone state to a nonamyloidogenic tetramer, which may prove to be a useful therapeutic strategy against TTR-associated CNS amyloidosis. 12779320

2003

dbSNP: rs61752717
rs61752717
0.100 GeneticVariation BEFREE In both cases, S1791 was in compound heterozygosity with MEFV mutation M694V, and the characteristic clinical syndrome of FMF including amyloidosis was found. 14636645

2004

dbSNP: rs61752717
rs61752717
0.100 GeneticVariation BEFREE The M694V and V726A allelic frequencies were, respectively, significantly higher and lower in the group with amyloidosis, compared to the control FMF group. 15018633

2004

dbSNP: rs28940579
rs28940579
0.030 GeneticVariation BEFREE The M694V and V726A allelic frequencies were, respectively, significantly higher and lower in the group with amyloidosis, compared to the control FMF group. 15018633

2004

dbSNP: rs3743930
rs3743930
0.040 GeneticVariation BEFREE The E148Q variant of MEFV was present in two of the three patients with TNF receptor-associated periodic syndrome (TRAPS) complicated by amyloid in two separate multiplex TRAPS families containing 5 and 16 affected members respectively, and the single patient with Muckle-Wells syndrome who had amyloidosis was homozygous for this variant. 15071491

2004

dbSNP: rs61752717
rs61752717
0.100 GeneticVariation BEFREE MEFV mutations are found to be increased both in FMF and non-FMF associated secondary amyloidosis in our study; however, no clear association between M694V and amyloidosis is observed, except in the non-FMF group. 15122067

2004

dbSNP: rs28940579
rs28940579
0.030 GeneticVariation BEFREE In this study, the frequencies of three FMF-related MEFV mutations (M694V, M680I and V726A) were investigated in FMF patients with (AA-FMF, n = 37) and without amyloidosis (non-AA-FMF, n = 35), in patients with secondary amyloidosis related to non-FMF inflammatory conditions (S-AA, n = 19) and in a non-inflammatory control group (n = 185) by molecular genetic studies using polymerase chain reaction with the ARMS (amplification refractory mutation system) method. 15122067

2004

dbSNP: rs28940580
rs28940580
0.010 GeneticVariation BEFREE In this study, the frequencies of three FMF-related MEFV mutations (M694V, M680I and V726A) were investigated in FMF patients with (AA-FMF, n = 37) and without amyloidosis (non-AA-FMF, n = 35), in patients with secondary amyloidosis related to non-FMF inflammatory conditions (S-AA, n = 19) and in a non-inflammatory control group (n = 185) by molecular genetic studies using polymerase chain reaction with the ARMS (amplification refractory mutation system) method. 15122067

2004